about
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (...
Read More
13.94
-0.40
(-2.79%)
1.1M
XNAS Volume
XNAS 17 Jun, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for CorMedix Inc is on 24 Jun 2025 for the purpose of Cormedix Inc Annual General Meeting for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
CorMedix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..